Introduction: Recently, the use of fetal echocardiography (FE) has increased due to the high incidence of congenital heart disease (CHD), specifically in high-risk pregnancies. FE has made it possible to optimize prenatal and postnatal care for critical CHD. The purpose of this study is to describe how FE is performed in the population of the Dominican Republic.
Methodology: This retrospective observational study was based on secondary data collected from 851 reports performed by a single operator over a 10-year period. Data collection was done using the RedCap database and data analysis was performed using STATA.
Results: CHD was detected in 36.3% of the study sample. Of these CHDs, 78.5% had structural abnormalities and 21.5% had functional abnormalities, while 16.6% had arrhythmias. A total of 82% of all referrals were made in the third trimester. Also 45.6% of all referrals were due to abnormal ultrasound findings and 46% of pregnancies had some form of exposure to medication.
Conclusion: FE pared with an exhaustive and timely maternal-prenatal history can provide an effective screening of CHD, when recommended for the general population. This benefits both mother and fetus by providing preventive approaches and an appropriate care plan.
Introduction: Recently, the use of fetal echocardiography (FE) has increased due to the high incidence of congenital heart disease (CHD), specifically in high-risk pregnancies. FE has made it possible to optimize prenatal and postnatal care for critical CHD. The purpose of this study is to describe how FE is performed in the population of the Dominican Republic.
Methodology: This retrospective observational study was based on secondary data collected from 851 reports performed by a single operator over a 10-year period. Data collection was done using the RedCap database and data analysis was performed using STATA.
Results: CHD was detected in 36.3% of the study sample. Of these CHDs, 78.5% had structural abnormalities and 21.5% had functional abnormalities, while 16.6% had arrhythmias. A total of 82% of all referrals were made in the third trimester. Also 45.6% of all referrals were due to abnormal ultrasound findings and 46% of pregnancies had some form of exposure to medication.
Conclusion: FE pared with an exhaustive and timely maternal-prenatal history can provide an effective screening of CHD, when recommended for the general population. This benefits both mother and fetus by providing preventive approaches and an appropriate care plan.
Wu W, He J, Shao X. Incidence and mortality trend of congenital heart disease at the global, regional, and national level, 1990–2017. Medicine. 2020;99(23). Available from: /pmc/articles/PMC7306355/
Van Der Linde D, Konings EEM, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJM, et al. Birth Prevalence of Congenital Heart Disease Worldwide: A Systematic Review and Meta-Analysis. J Am Coll Cardiol. 2011;58(21):2241–7. Available from: www.jacc.org/doi/10.1016/j.jacc.2011.08.025
Zimmerman MS, Smith AGC, Sable CA, Echko MM, Wilner LB, Olsen HE, et al. Global, regional, and national burden of congenital heart disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Child Adolesc Health. 2020;4(3):185–200. Available from: www.thelancet.com/article/S235246421930402X/fulltext
Oster ME, Lee KA, Honein MA, Riehle-Colarusso T, Shin M, Correa A. Temporal trends in survival among infants with critical congenital heart defects. Pediatrics [Internet]. 2013 May [cited 2023 Jun 18];131(5). Available from: http://pubmed.ncbi.nlm.nih.gov/23610203/
Mortera C, Barcelona HH. Ecocardiografía fetal. Anatomía y fisiología normal del feto. In: Protocolos diagnósticos y terapéuticos en cardiología pediátrica Unidad de Cardiología Pediátrica, Hospital San Juan de Dios, HCP Barcelona. Disponible en: https://www.aeped.es/sites/default/files/documentos/37_eco_fetal.pdf; 2013. p. 1–14.
Reyes A. Más de un 80 % de las muertes maternas y neonatales son evitables. UNICEF República Dominicana; 2021. Available from:
Pierpont ME, Brueckner M, Chung WK, Garg V, Lacro R V., McGuire AL, et al. Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement from the American Heart Association. Circulation. 2018;138(21):e653–711. Available from: www.ahajournals.org/doi/abs/10.1161/CIR.0000000000000606
Zurita Peralta J, Sosa Olavarría A, Zielinsky P. Revisión A DE. Sonographic fetal cardiac function evaluation.
Carvalho JS., Allan LD, Copel JA., DeVore GR., Hecher K, Lee W, et al. ISUOG Practice Guidelines (updated): sonographic screening examination of the fetal heart. Ultrasound in Obstetrics and Gynecology. 2013;41:348–59.
Crane JP, LeFevre ML, Winborn RC, Evans JK, Ewigman BG, Bain RP, et al. A randomized trial of prenatal ultrasonographic screening: impact on the detection, management, and outcome of anomalous fetuses. The RADIUS Study Group. Am J Obstet Gynecol.1994;171(2):392–9. Available from: https://pubmed.ncbi.nlm.nih.gov/8059817/
Anderson RH, Becker AE, Freedom RM, Macartney FJ, Quero-Jimenez M, Shinebourne EA, et al. Sequential segmental analysis of congenital heart disease. Pediatric Cardiology 1984;5(4):281–7. Available from: https://link.springer.com/article/10.1007/BF02424973
Rajiah P, Mak C, Dubinksy TJ, Dighe M. Ultrasound of Fetal Cardiac Anomalies. 2012;197(4). Available from: http://dx.doi.org/102214/AJR107287
Yeo L, Romero R. Fetal Intelligent Navigation Echocardiography (FINE): a novel method for rapid, simple, and automatic examination of the fetal heart. Ultrasound in Obstetrics & Gynecology. 2013;42(3):268–84. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/uog.12563
Guzzo De León D. Análisis secuencial segmentario para el diagnóstico de cardiopatías congénitas: El aporte de la radiología, del electrocardiograma y de la ecocardiografía. Revista Uruguaya de Cardiología. 2008;23(1):21–48. Available from: http://www.scielo.edu.uy/scielo.php?script=sci_arttex-t&pid=S1688-04202008000100004&lng=es&nrm=iso&tlng=es
Miller GAH, Anderson RH, Rigby ML. The diagnosis of congenital heart disease: incorporating the Brompton Hospital Diagnostic Code. Castle House Publications; 1985.
Agarwal A, Roen-Padilla S, Khemani J, Osmolovsky M, Amirtharaj C, Bhutada A, et al. Fetal echocardiography — A recent four year experience from a single urban center. Prog Pediatr Cardiol. 2016;43:95–7.
Charafeddine F, Hachem A, Kibbi N, Abutaqa M, Bitar F, Bulbul Z, et al. The first Fetal Echocardiography experience for Prenatal diagnosis of Congenital Heart Disease in Lebanon: Successes and challenges. J Saudi Heart Assoc. 2019;31(3):125. Available from: /pmc/articles/PMC6503121/